Unum [UNM] vs MetLife [MET] Detailed Stock Comparison
Unum
NYSE
Loading...
MetLife
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Unum wins in 11 metrics, MetLife wins in 8 metrics, with 0 ties. Unum appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Unum | MetLife | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 8.39 | 12.23 | Unum |
| Price-to-Book Ratio | 1.06 | 1.83 | Unum |
| Debt-to-Equity Ratio | 35.58 | 172.75 | Unum |
| PEG Ratio | 7.74 | 7.72 | MetLife |
| EV/EBITDA | 5.52 | 8.98 | Unum |
| Profit Margin (TTM) | 11.77% | 6.13% | Unum |
| Operating Margin (TTM) | 13.95% | 10.29% | Unum |
| EBITDA Margin (TTM) | 13.95% | 10.29% | Unum |
| Return on Equity | 13.95% | 15.98% | MetLife |
| Return on Assets (TTM) | 2.14% | 0.63% | Unum |
| Free Cash Flow (TTM) | $1.39B | $14.60B | MetLife |
| Dividend Yield | 1.61% | 2.10% | MetLife |
| 1-Year Return | 31.44% | 8.30% | Unum |
| Price-to-Sales Ratio (TTM) | 0.92 | 0.68 | MetLife |
| Enterprise Value | $12.46B | $67.82B | MetLife |
| EV/Revenue Ratio | 0.97 | 0.92 | MetLife |
| Revenue per Share (TTM) | $72 | $106 | MetLife |
| Earnings per Share (Diluted) | $8.34 | $6.12 | Unum |
| Beta (Stock Volatility) | 0.40 | 0.83 | Unum |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Unum vs MetLife Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Unum | 1.25% | -4.54% | -16.13% | -14.86% | -10.92% | -6.01% |
| MetLife | 3.35% | -2.80% | -6.77% | -3.81% | -12.04% | -9.73% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Unum | 31.44% | 81.25% | 270.03% | 94.99% | 238.73% | 260.01% |
| MetLife | 8.30% | 12.00% | 91.74% | 55.60% | 115.40% | 74.76% |
Performance & Financial Health Analysis: Unum vs MetLife
| Metric | UNM | MET |
|---|---|---|
| Market Information | ||
| Market Cap | $11.92B | $50.23B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 2,227,651 | 3,359,243 |
| 90 Day Avg. Volume | 1,528,714 | 2,902,111 |
| Last Close | $69.41 | $76.29 |
| 52 Week Range | $52.65 - $84.48 | $65.21 - $89.05 |
| % from 52W High | -17.84% | -14.33% |
| All-Time High | $84.48 (Mar 24, 2025) | $89.05 (Nov 25, 2024) |
| % from All-Time High | -17.84% | -14.33% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.16% |
| Quarterly Earnings Growth | -0.14% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.06% |
| Operating Margin (TTM) | 0.14% | 0.10% |
| Return on Equity (TTM) | 0.14% | 0.16% |
| Debt to Equity (MRQ) | 35.58 | 172.75 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $65.76 | $40.83 |
| Cash per Share (MRQ) | $20.44 | $44.80 |
| Operating Cash Flow (TTM) | $1.58B | $16.53B |
| Levered Free Cash Flow (TTM) | $1.58B | $1.66B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.61% | 2.10% |
| Last 12-Month Dividend | $1.26 | $1.65 |
Valuation & Enterprise Metrics Analysis: Unum vs MetLife
| Metric | UNM | MET |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 8.39 | 12.23 |
| Forward P/E | 7.74 | 7.72 |
| PEG Ratio | 7.74 | 7.72 |
| Price to Sales (TTM) | 0.92 | 0.68 |
| Price to Book (MRQ) | 1.06 | 1.83 |
| Market Capitalization | ||
| Market Capitalization | $11.92B | $50.23B |
| Enterprise Value | $12.46B | $67.82B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.97 | 0.92 |
| Enterprise to EBITDA | 5.52 | 8.98 |
| Risk & Other Metrics | ||
| Beta | 0.40 | 0.83 |
| Book Value per Share (MRQ) | $65.76 | $40.83 |
Financial Statements Comparison: Unum vs MetLife
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | UNM | MET |
|---|---|---|
| Revenue/Sales | $3.35B | $18.28B |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $417.00M | $1.35B |
| Income Tax | $81.40M | $404.00M |
| Net Income (Profit) | $335.60M | $950.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | UNM | MET |
|---|---|---|
| Cash & Equivalents | $237.70M | $21.33B |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $3.47B | $18.85B |
| Total Shareholders Equity | $11.21B | $27.76B |
| Retained Earnings | $13.03B | $43.13B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | UNM | MET |
|---|---|---|
| Operating Cash Flow | $392.50M | N/A |
| Capital Expenditures | $-35.80M | N/A |
| Free Cash Flow | $317.80M | $4.26B |
| Debt Repayment | N/A | $-810.00M |
| Common Stock Repurchase | $-200.50M | $-1.41B |
Short Interest & Institutional Ownership Analysis
| Metric | UNM | MET |
|---|---|---|
| Shares Short | 2.20M | 8.07M |
| Short Ratio | 1.61 | 2.76 |
| Short % of Float | 0.02% | 0.01% |
| Average Daily Volume (10 Day) | 2,227,651 | 3,359,243 |
| Average Daily Volume (90 Day) | 1,528,714 | 2,902,111 |
| Shares Outstanding | 178.59M | 689.21M |
| Float Shares | 155.02M | 559.83M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 0.94% | 0.92% |
Dividend Analysis & Yield Comparison: Unum vs MetLife
| Metric | UNM | MET |
|---|---|---|
| Last 12-Month Dividend | $1.26 | $1.65 |
| Last 12-Month Dividend Yield | 1.61% | 2.10% |
| 3-Year Avg Annual Dividend | $1.34 | $1.93 |
| 3-Year Avg Dividend Yield | 0.76% | 0.77% |
| 3-Year Total Dividends | $4.02 | $5.78 |
| Ex-Dividend Date | Jan 24, 2025 | Feb 04, 2025 |